PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.54%
Similar revenue growth to CRWV's 23.55%. Walter Schloss would investigate if similar growth reflects similar quality.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.54%
EBITDA growth 50-75% of CRWV's 33.05%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
18.54%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
-18.54%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.10%
Share count reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.
-0.10%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.